{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:24:49Z","timestamp":1760955889147,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.thromres.2018.09.049","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T06:27:10Z","timestamp":1537597630000},"page":"74-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0949-1558","authenticated-orcid":false,"given":"Far\u00e8s","family":"Moustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Stehouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Kamphuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Carles","family":"Sahuquillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Samp\u00e9riz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Suri\u00f1ach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngeles","family":"Blanco-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Mismetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-0767","authenticated-orcid":false,"given":"Manuel","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2018.09.049_bb0005","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.V78.9.2337.2337","article-title":"Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin","volume":"78","author":"Nieuwenhuis","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.09.049_bb0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis","volume":"139","author":"Linkins","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2018.09.049_bb0015","doi-asserted-by":"crossref","first-page":"I10","DOI":"10.1161\/01.CIR.0000140902.46296.ae","article-title":"Long-term management of patients after venous thromboembolism","volume":"110","author":"Kearon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2018.09.049_bb0020","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.thromres.2010.06.017","article-title":"French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)","volume":"126","author":"Pernod","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.09.049_bb0025","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2018.09.049_bb0030","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc12685","article-title":"Management of bleeding and coagulopathy following major trauma: an updated European guideline","volume":"17","author":"Spahn","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2018.09.049_bb0035","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.jacc.2017.09.1085","article-title":"2017 ACC expert consensus decision pathway on Management of Bleeding in patients on Oral anticoagulants","volume":"70","author":"Tomaselli","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2018.09.049_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2017.12.003","article-title":"Current evidence of oral anticoagulant reversal: a systematic review","volume":"162","author":"Tornkvist","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.09.049_bb0045","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jacc.2014.01.058","article-title":"Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk","volume":"63","author":"Muriel","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2018.09.049_bb0050","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1016\/j.jvs.2011.05.114","article-title":"Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis","volume":"54","author":"Mu\u00f1oz-Torrero","year":"2011","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.thromres.2018.09.049_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001235","article-title":"Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism","volume":"94","author":"Farge","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2018.09.049_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacc.2015.10.060","article-title":"Trends in the management and outcomes of acute pulmonary embolism analysis from the RIETE registry","volume":"67","author":"Jim\u00e9nez","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2018.09.049_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1160\/TH17-07-0511","article-title":"Rationale, design and methodology of the computerized registry of patients with venous thromboembolism (RIETE)","volume":"118","author":"Bikdeli","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.09.049_bb0070","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2018.09.049_bb0075","first-page":"141","article-title":"Evidence-based management of anticoagulant therapy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2018.09.049_bb0080","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/europace\/eur126","article-title":"Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European heart rhythm association, endorsed by the European Society of Cardiology Working Group on thrombosis introduction and scope","volume":"13","author":"Lip","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.thromres.2018.09.049_bb0085","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.113.002332","article-title":"Management and outcomes of major bleeding during treatment with dabigatran or warfarin","volume":"128","author":"Majeed","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2018.09.049_bb0090","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2018.09.049_bb0095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1160\/TH16-04-0266","article-title":"Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal a systematic review and meta-analysis","volume":"1165","author":"Chai-Adisaksopha","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.09.049_bb0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-137-4-200208200-00009","article-title":"Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial","volume":"137","author":"Crowther","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2018.09.049_bb0105","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1055\/s-0037-1615026","article-title":"Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin","volume":"79","author":"Crowther","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.09.049_bb0110","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1592\/phco.23.12.1245.32701","article-title":"A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin","volume":"23","author":"Fan","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.thromres.2018.09.049_bb0115","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1345\/aph.1R497","article-title":"Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute\/critical care setting","volume":"46","author":"Tsu","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.thromres.2018.09.049_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1537-2995.2012.03755.x","article-title":"Clinical experience with oral versus intravenous vitamin K for warfarin reversal (CME)","volume":"53","author":"Meehan","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2018.09.049_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00129784-200404010-00005","article-title":"The use of vitamin K in patients on anticoagulant therapy: a practical guide","volume":"4","author":"Hanslik","year":"2004","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.thromres.2018.09.049_bb0130","first-page":"87","article-title":"Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience","volume":"10","author":"Barillari","year":"2012","journal-title":"Blood Transfus."},{"key":"10.1016\/j.thromres.2018.09.049_bb0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jth.12148","article-title":"Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome","volume":"11","author":"Halbritter","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.09.049_bb0140","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(14)61685-8","article-title":"Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial","volume":"385","author":"Goldstein","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2018.09.049_bb0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.thromres.2018.09.049_bb0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cll.2014.06.002","article-title":"Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal","volume":"34","author":"Sarode","year":"2014","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.thromres.2018.09.049_bb0155","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/acem.12911","article-title":"Safety of a four-factor prothrombin complex concentrate versus plasma for vitamin K antagonist reversal: an integrated analysis of two phase IIIb clinical trials","volume":"23","author":"Milling","year":"2016","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.thromres.2018.09.049_bb0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1740774507087972","article-title":"Do we need to adjudicate major clinical events?","volume":"5","author":"Granger","year":"2008","journal-title":"Clin. Trials"},{"key":"10.1016\/j.thromres.2018.09.049_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1740774509105223","article-title":"Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs","volume":"6","author":"Pogue","year":"2009","journal-title":"Clin. Trials"},{"key":"10.1016\/j.thromres.2018.09.049_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055807","article-title":"Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial","volume":"8","author":"Hata","year":"2013","journal-title":"PLoS One"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818305334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818305334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:38:24Z","timestamp":1758735504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818305334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":34,"alternative-id":["S0049384818305334"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.09.049","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}